Forbes profiles Amy Feldman, senior editor covering healthcare industry trends

Amy Feldman's reporting provides critical insights into the healthcare and pharmaceutical industries. Her analysis includes examinations of the potential ramifications of a government shutdown on the sector and evaluations of significant corporate actions, such as Pfizer's pricing agreements and their impact on regulatory stability. Feldman's coverage, notably featured in the "InnovationRx" newsletter, emphasizes pivotal industry news and emerging trends. This includes reporting on Nobel Prize laureates in medicine, Amgen's direct-to-consumer marketing strategies, and executive leadership transitions at prominent health systems. Her articles also showcase profiles of innovative biotech entrepreneurs, such as the founder of a company dedicated to developing treatments for brain diseases.